Hedge Fund Boone Capital Stake in HealthEquity: Is It a Buy?
Boone Capital just disclosed a fresh position in HealthEquity, raising questions about the stock's potential. This gu...
Timing a rebalance for blue chip crypto holdings relies on predefined thresholds and market conditions. Use objective signals to keep allocation aligned with goals.
13,268 articlesBoone Capital just disclosed a fresh position in HealthEquity, raising questions about the stock's potential. This gu...
As Berkshire Hathaway enters a new chapter, investors wonder if berkshire's just break from Buffett's time-tested pla...
One staffing stock plunged 56% in the last year, but a large new stake worth almost $10 million could signal a forthc...
Two pharma giants, two very different growth stories. This guide breaks down why Eli Lilly might be the best growth s...
PepsiCo unveils a landmark Asia strategy, reframing markets into three asias, three different playbooks to capture gr...
A Texas Capital BancShares board member purchased 1,000 shares at $91.50 per share as the stock price weakened. This ...
A major European energy firm plans to halt offshore wind projects off the U.S. East Coast and redirect about $1B into...
When AI dominates headlines, investors often fear every software stock will crumble. This piece digs into whether fig...
Oil prices surge on geopolitical tensions, lifting energy stocks. This article examines a single ETF that could benef...
Vanguard's consumer staples ETF outperforms a sagging broader market, underscoring the pull of essential goods during...
Grab stock has faced a meaningful pullback, prompting many investors to ask whether a dip presents a buying opportuni...
As Reynolds prepares to report its 2026 earnings, investors are weighing growth catalysts, margin resilience, and pot...